- Home
- HURA vs CCRD Comparison
HURA vs CCRD Comparison
Compare HURA & CCRD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HURA
- CCRD
- Stock Information
- Founded
- HURA 2009
- CCRD 1973
- Country
- HURA United States
- CCRD United States
- Employees
- HURA N/A
- CCRD N/A
- Industry
- HURA
- CCRD
- Sector
- HURA
- CCRD
- Exchange
- HURA Nasdaq
- CCRD Nasdaq
- Market Cap
- HURA 171.7M
- CCRD 157.9M
- IPO Year
- HURA N/A
- CCRD N/A
- Fundamental
- Price
- HURA $2.26
- CCRD $29.00
- Analyst Decision
- HURA Strong Buy
- CCRD Hold
- Analyst Count
- HURA 2
- CCRD 1
- Target Price
- HURA $11.50
- CCRD $21.00
- AVG Volume (30 Days)
- HURA 401.7K
- CCRD 107.1K
- Earning Date
- HURA 08-15-2025
- CCRD 07-31-2025
- Dividend Yield
- HURA N/A
- CCRD N/A
- EPS Growth
- HURA N/A
- CCRD 187.14
- EPS
- HURA N/A
- CCRD 0.86
- Revenue
- HURA N/A
- CCRD $61,011,000.00
- Revenue This Year
- HURA N/A
- CCRD $17.35
- Revenue Next Year
- HURA $69.15
- CCRD N/A
- P/E Ratio
- HURA N/A
- CCRD $32.70
- Revenue Growth
- HURA N/A
- CCRD 12.31
- 52 Week Low
- HURA $1.80
- CCRD $11.57
- 52 Week High
- HURA $13.13
- CCRD $31.99
- Technical
- Relative Strength Index (RSI)
- HURA N/A
- CCRD 58.79
- Support Level
- HURA N/A
- CCRD $27.74
- Resistance Level
- HURA N/A
- CCRD $29.97
- Average True Range (ATR)
- HURA 0.00
- CCRD 1.15
- MACD
- HURA 0.00
- CCRD -0.30
- Stochastic Oscillator
- HURA 0.00
- CCRD 29.16
About HURA TuHURA Biosciences Inc. Common Stock
TuHURA Biosciences Inc is a Phase 3 registration stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. It is preparing to initiate a single randomized placebo-controlled Phase 3 registration trial of IFx-2.0 administered as an adjunctive therapy to Keytruda (pembrolizumab) in first-line treatment for advanced or metastatic Merkel Cell Carcinoma.
About CCRD CoreCard Corporation
CoreCard Corp is engaged in the business of providing technology solutions and processing services to the financial technology and services market. It designs, develops and markets a comprehensive suite of software solutions to program managers, accounts receivable businesses, financial institutions, retailers and processors to manage their credit and debit cards, prepaid cards, private label cards, fleet cards, buy now pay later programs, loyalty programs and accounts receivable and loan transactions. The CoreCard software platform and modules include CoreENGINE, CoreISSUE, CoreFRAUD, CoreCOLLECT, CoreAPP, CoreMONEY and CoreACQUIRE. Its customers are located in the U.S, European Union and the Middle East of which key revenue is derived from the U.S.